# Alltracel Pharma, Ltd.

- Location (FDA's records): Chapel Hill, NC
- FDA decisions: 1 (2002–2002): 1 510(k) clearance
- Product codes: QSY (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 6 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Innovative Technologies, Ltd.: 1 (https://510kreport.com/company/innovative-technologies)
- Dermaphylyx, Inc.: 1 (https://510kreport.com/company/dermaphylyx)
- Medtrade Products, Ltd.: 1 (https://510kreport.com/company/medtrade-products)

## Firms that cite its devices most
- Lifescience Plus, Inc.: 2 (https://510kreport.com/company/lifescience-plus)
- Hemcon Medical Technologies Europe, Ltd.: 2 (https://510kreport.com/company/hemcon-medical-technologies-europe)
- Radi Medical Systems AB: 1 (https://510kreport.com/company/radi-medical-systems)
- Bc3 Technologies, Inc.: 1 (https://510kreport.com/company/bc3-technologies)

## Its most-cited devices
- K010933: Seal-on Topical Hempstatic Powder Spray (2002), cited by 6

## Recent decisions
- K010933: Seal-on Topical Hempstatic Powder Spray (Jan 8, 2002)

Source page: https://510kreport.com/company/alltracel-pharma